Related Experiment Video
Updated: Jul 5, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Notch inhibits osteoblast differentiation and causes osteopenia
Stefano Zanotti1, Anna Smerdel-Ramoya, Lisa Stadmeyer
1Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299, USA.
Notch signaling in osteoblasts leads to osteopenia by impairing bone formation. Overexpression of Notch intracellular domain (NICD) reduces bone volume and inhibits osteoblastogenesis via Wnt/beta-catenin pathway disruption.
Area of Science:
- Cell Biology
- Skeletal Biology
- Developmental Biology
Background:
- Notch receptors are crucial for cell fate determination.
- The role of Notch signaling in the adult skeleton requires further elucidation.
- Understanding Notch's skeletal function is key to addressing bone diseases.
Purpose of the Study:
- To investigate the impact of Notch signaling on adult bone homeostasis.
- To define the specific mechanisms by which Notch affects osteoblast and osteoclast function.
- To explore the therapeutic potential of modulating Notch signaling in skeletal disorders.
Main Methods:
- Generation of transgenic mice overexpressing Notch intracellular domain (NICD) under the type I collagen promoter.
- In vitro studies using osteoblasts and stromal cells with induced NICD expression via adenoviral Cre recombinase.
- Generation of conditional null notch1 mice and assessment of skeletal phenotypes.
Main Results:
- NICD overexpression in transgenic mice resulted in osteopenia, reduced bone volume, and decreased osteoblast and osteoclast numbers.
- In vitro, NICD impaired osteoblastogenesis and inhibited Wnt/beta-catenin signaling.
- Conditional notch1 deletion showed minimal skeletal effects, suggesting potential redundancy with Notch2, but revealed modest increases in osteoclast activity in females.
Conclusions:
- Notch signaling in osteoblasts directly contributes to osteopenia.
- Impaired osteoblastogenesis and inhibition of Wnt/beta-catenin signaling are key mechanisms.
- Modulating Notch signaling presents a potential therapeutic avenue for bone diseases.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
